Laura Weston

Pharmaceutical scientist with over 20 years of experience facilitating the development, approval and launch of novel small molecule and biologic drug products. Expertise in preparing CMC sections of regulatory filings, method development and validation, contract facility oversight (domestic and ex-US), regulatory compliance, building teams, and formulation development. Strengths include project management, international partner relations, system development, and technical writing.

Before joining Atheln, Laura was Sr. Director, Pharmaceutical Technology at Santarus Inc. where she worked for thirteen years holding positions of increasing responsibility. As Sr. Director, she provided technical direction, strategic planning, and leadership for the group responsible for supporting the development and commercialization of small molecule and biologic products. Conducted strategic due diligence analysis, participated in audits, and made specific recommendations relating to new product acquisitions, mergers, and partnerships. Prior to Santarus, Laura spent six years at Elan Pharmaceuticals and three years at Molecular Biosystems.

Laura holds and MBA from the University of Southern California and a BS in Chemistry from the University of California Davis.